Author pages are created from data sourced from our academic publisher partnerships and public sources.
Estimating the Budget Impact of Switching from Bortezomib Intravenous (Iv) to Bortezomib Subcutaneous (Sq) in the Treatment of Relapsed/Refractory Multiple Myeloma (Mm) in Mexico.
Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared With Cabacitaxel in Costa Rica, in Patients with Metastatic Castration-Resistant Prostate Cancer That Have Failed to Chemotherapy…
Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in Dominican Republic, in Patients With Metastatic Castration-Resistant Prostate Cancer that Have Failed to…
- C. Obando, Z. Desanvicente-Celis, L. González, D. Muschett, F. Gonzalez, P. Goldberg
- Value in health : the journal of the…
PCN121 Cost-EffECtivENEss ANAlysis of AbirAtEroNE ACEtAtE trEAtmENt ComPArEd with CAbACitAxEl iN domiNiCAN rEPubliC, iN PAtiENts with mEtAstAtiC CAstrAtioN-rEsistANt ProstAtE CANCEr thAt hAvE fAilEd… Expand
A Budget Impact Model Estimating the Financial Impact of Increased Use of Generic Bortezomib Intravenous (Iv) in the Treatment of Relapsed/Refractory Multiple Myeloma (Mm) in Venezuela.
Cost-Effectiveness Analysis of Abiraterone Acetate Treatment Compared with Cabacitaxel in the Republic of Panama, in Patients with Metastatic Castration-Resistant Prostate Cancer that Have Failed to…
The Cost-Effectiveness of Bendamustine-Rituximab (Ben-R) Versus R-Chop for the First Line Treatment of Patients with Indolent Non-Hodgkin's Lymphoma (Inhl) in Colombia.
Cost/Benefit Analysis of First Line Chronic Lymphocytic Leukemia (CLL) Treatments in Mexico
Cost-Effectiveness of Bendamustine Versus Fludarabine for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) in Colombia
PND43 ECONOMIC EVALUATION OF FINGOLIMOD COMPARED TO INTERFERON-β1A IN THE TREATMENT OF PEDIATRIC-ONSET MULTIPLE SCLEROSIS (POMS) IN MEXICO